Physician profile
Mirza Beg
NPI 1710911268
$236.17
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.87 · 2020: $18.94 · 2021: $68.84 · 2022: $10.27 · 2023: $26.18 · 2024: $63.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $40.79 | 2024 | Qutenza |
| Gilead Sciences, INC. | $26.18 | 2023 | |
| Biogen, INC. | $22.28 | 2024 | Avonex, Tysabri, Vumerity |
| Virtus Pharmaceuticals LLC | $19.23 | 2021 | |
| Glaxosmithkline, LLC. | $18.94 | 2020 | |
| Upsher-Smith Laboratories LLC | $18.70 | 2019 | |
| Merck Sharp & Dohme LLC | $18.57 | 2021 | |
| Csl Behring | $17.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.05 | 2021 | |
| Lilly USA, LLC | $14.99 | 2021 | |
| Supernus Pharmaceuticals, INC. | $12.18 | 2019 | |
| Advanced Oxygen Therapy INC. | $10.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirza Beg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.